Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("JENNER, P")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 428

  • Page / 18
Export

Selection :

  • and

LES NOMS DE NOMBRE EN KHMERJENNER P. N.JOURNAL ASIATIQUE. 1974, Vol 262, Num 1-2, pp 171-191Article

NOVEL PATHWAYS IN DRUG METABOLISM.JENNER P.1978; XENOBIOTICA; G.B.; DA. 1978; VOL. 8; NO 1; PP. 1-25; BIBL. 2 P. 1/2Article

Les cpap ou codes de conduite khmers. II. cpap prusJENNER P. N; POU S.Bulletin de l'Ecole Française d'Extrême-Orient. 1976, Vol 63, pp 313-350Article

THE INFLUENCE OF PIRIBEDIL (ET 495) ON COMPONENTS OF LOCOMOTOR ACTIVITY. = L'INFLUENCE DU PIRIBEDIL (ET 495) SUR LES COMPOSANTES DE L'ACTIVITE MOTRICEJENNER P; MARSDEN CD.1975; EUROP. J. PHARMACOL.; NETHERL.; DA. 1975; VOL. 33; NO 1; PP. 211-215; BIBL. 17 REF.Article

What process causes nigral cell death in Parkinson's diseaseJENNER, P.Neurologic clinics. 1992, Vol 10, Num 2, pp 387-403, issn 0733-8619Article

THE CONCEPT OF REGIOSELECTIVITY IN DRUG METABOLISM.TESTA B; JENNER P.1976; J. PHARM. PHARMACOL.; G.B.; DA. 1976; VOL. 28; NO 10; PP. 731-744; BIBL. 1 P. 1/2Article

THE METABOLISM OF TOBACCO ALKALOIDSGORROD JW; JENNER P.1975; ESSAYS IN TOXICOL.; U.S.A.; DA. 1975; VOL. 6; PP. 35-78; BIBL. 6P.Article

CIRCULAR DICHROIC DETERMINATION OF THE PREFERRED CONFORMATION OF NICOTINE AND RELATED CHIRAL ALKALOIDS IN AQUEOUS SOLUTION = DETERMINATION DU DICHROISME CIRCULAIRE DE LA CONFIGURATION PREFERENTIELLE DE LA NICOTINE ET DES ALCALOIDES SPATIALEMENT APPARENTES EN SOLUTION AQUEUSETESTA B; JENNER P.1973; MOLEC. PHARMACOL.; U.S.A.; DA. 1973; VOL. 9; NO 1; PP. 10-16; BIBL. 1 P.Serial Issue

POSSIBLE NEURONAL MECHANISMS INVOLVED IN THE PRODUCTION OF THE DISINHIBITORY ACTION OF SULPIRIDEJENNER P; MARSDEN CD.1981; ADV. BIOL. PSYCHIATRY; ISSN 0378-7354; CHE; DA. 1981; VOL. 7; PP. 100-112; BIBL. 3 P.Article

Oxidative stress in Parkinson's disease and other neurodegenerative disordersJENNER, P.Pathologie et biologie. 1996, Vol 44, Num 1, pp 57-64, issn 0369-8114Conference Paper

Oxidative damage in neurodegenerative diseaseJENNER, P.Lancet (British edition). 1994, Vol 344, Num 8925, pp 796-798, issn 0140-6736Article

Oxidative stress as a cause of Parkinson's diseaseJENNER, P.Acta neurologica Scandinavica. Supplementum. 1991, Vol 84, Num 136, pp 6-15, issn 0065-1427Article

Clues to the mechanism underlying dopamine cell death in Parkinson's diseaseJENNER, P.Journal of neurology, neurosurgery and psychiatry. 1989, pp 22-28, issn 0022-3050, 7 p., supplArticle

INHIBITORS OF CYTOCHROME P-450S AND THEIR MECHANISM OF ACTIONTESTA B; JENNER P.1981; DRUG METAB. REV. (SOFTCOVER ED.); ISSN 0360-2532; USA; DA. 1981; VOL. 12; NO 1; PP. 1-117; BIBL. 236 REF.Article

THE SUBSTITUTED BENZAMIDES: A NOVEL CLASS OF DOPAMINE ANTAGONISTSJENNER P; MARSDEN CD.1979; LIFE SCI.; GBR; DA. 1979; VOL. 25; NO 6; PP. 479-485; BIBL. 74 REF.Article

METABOLIC N-OXIDATION PRODUCTS OF ALIPHATIC AMINES AS POTENTIAL MEDIATORS IN AMINE PHARMACOLOGY. = PRODUITS DE N-OXYDATION METABOLIQUE DES AMINES ALIPHATIQUES COMME MEDIATEURS POSSIBLES DANS LA PHARMACOLOGIE DES AMINESGORROD JW; JENNER P.1975; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1975; VOL. 12; NO 1-2; PP. 180-185; BIBL. 20 REF.; (VITH INT. SYMP. CLIN. PHARMACOL.; REGENSBURG, GER.; 1974)Conference Paper

THE PATHOPHYSIOLOGY OF EXTRAPYRAMIDAL SIDE-EFFECTS OF NEUROLEPTIC DRUGSMARSDEN CD; JENNER P.1980; PSYCHOL. MED.; GBR; DA. 1980; VOL. 10; NO 1; PP. 55-72; BIBL. 4 P.Article

Pré-Angkorien Gnih and Gnoh and the Syntax of GiJENNER, P. N.Asie du Sud-Est et Monde Insulindien Paris. 1982, Vol 13, Num 1-4, pp 143-153Article

RELATIONSHIP BETWEEN PLASMA PROPRANOLOL CONCENTRATION AND RELIEF OF ESSENTIAL TREMORJEFFERSON D; JENNER P; MARSDEN CD et al.1979; J. NEUROL. NEUROSURG. PSYCHIATRY; GBR; DA. 1979; VOL. 42; NO 9; PP. 831-837; BIBL. 1 P.Article

ATROPINE MANIPULATION OF ELEVATED CEREBRAL DOPAMINE TURNOVER CAUSED BY HALOPERIDOL OR SUBSTITUTED BENZAMIDE DRUGSELLIOTT PNC; JENNER P; MARSDEN CD et al.1978; J. PHARM. PHARMACOL.; GBR; DA. 1978; VOL. 30; NO 12; PP. 788-791; BIBL. 28 REF.Article

SEROTONIN METABOLISM IN HUMAN EPILEPSY: THE INFLUENCE OF ANTICONVULSANT DRUGS.CHADWICK D; JENNER P; REYNOLDS EH et al.1977; ANN. NEUROL.; U.S.A.; DA. 1977; VOL. 1; NO 3; PP. 218-224; BIBL. 1 P.Article

THE IRRITANT PROPERTIES OF DOPAMINE-BETA -HYDROXYLASE INHIBITORS IN RELATION TO THEIR EFFECTS ON L-DOPA-INDUCED LOCOMOTOR ACTIVITY.DOLPHIN A; ELLIOTT PNC; JENNER P et al.1976; J. PHARM. PHARMACOL.; G.B.; DA. 1976; VOL. 28; NO 10; PP. 782-785; BIBL. 14 REF.Article

CATION SPECIFICITY OF 3H-SULPIRIDE BINDING INVOLVES ALTERATION IN THE NUMBER OF STRIATAL BINDING SITESTHEODOROU AE; JENNER P; MARSDEN CD et al.1983; LIFE SCIENCES(1973; ISSN 0024-3205; GBR; DA. 1983; VOL. 32; NO 11; PP. 1243-1254; BIBL. 22 REF.Article

CHOLINERGIC MANIPULATION OF PERIORAL BEHAVIOUR INDUCED BY CHRONIC NEUROLEPTIC ADMINISTRATION TO RATSRUPNIAK NMJ; JENNER P; MARSDEN CD et al.1983; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1983; VOL. 79; NO 2-3; PP. 226-230; BIBL. 25 REF.Article

High-performance liquid chromatographic determination of thiacetazone in body fluidsJENNER, P. J.Journal of chromatography. 1983, Vol 276, Num 2, pp 463-470, issn 0021-9673Article

  • Page / 18